|
× |
 |
Efficacy, Safety, and Tolerability of Desvenlafaxine 50 mg/d for the Treatment of Major Depressive Disorder: A Systematic Review of Clinical Trials PDF |
$40.00 |
|
$40.00 |
|
× |
|
Tiagabine Appears Not to Be Efficacious in the Treatment of Acute Mania PDF |
$40.00 |
|
$40.00 |
|
× |
|
Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Evolution of Psychopharmacology Trial Design and Analysis: Six Decades in the Making PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Critical Appraisal of Treatments for Bipolar Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Risk Factors for Filicide and Homicide: 36-Year National Matched Cohort Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Many Thanks PDF |
$40.00 |
|
$40.00 |
|
× |
|
Haloperidol-Induced Acute Generalized Exanthematous Pustulosis: A Rare Side Effect PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prevention of Recurrent Postpartum Depression: A Randomized Clinical Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effects of Parental Opioid Use: Outcomes of Children of Parents in Medication-Assisted Treatment Compared to Healthy Controls PDF |
$40.00 |
|
$40.00 |
|
× |
|
COVID-19–Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine PDF |
$40.00 |
|
$40.00 |
|
× |
|
National Trends in the Outpatient Treatment of Anxiety Disorders PDF |
$40.00 |
|
$40.00 |
|
|
